These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3311984)

  • 1. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1987 May; 16(3):263-71. PubMed ID: 3311984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1986 Dec; 15(8):791-9. PubMed ID: 3298026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus.
    Asplin CM; Hollander P; Pecoraro RE; Brodsky J; Palmer JP
    Diabetes Care; 1981; 4(3):337-42. PubMed ID: 7047110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.
    Giannarelli R; Marchetti P; Giannecchini M; Di Cianni G; Cecchetti P; Masoni A; Navalesi R
    Acta Diabetol Lat; 1988; 25(3):257-62. PubMed ID: 3071067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious effect of anti-insulin antibodies on diabetes control.
    Livneh A; Avraham H; Bistritzer T; Weisglass L; Theodor R; Sack J
    Isr J Med Sci; 1990 Jan; 26(1):11-5. PubMed ID: 2179155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study.
    Zhu J; Yuan L; Ni WJ; Luo Y; Ma JH
    J Diabetes Res; 2019; 2019():7304140. PubMed ID: 31687408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
    Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
    J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Hoffman RM; Duckworth WC; Wendel CS; Shah JH;
    Am J Med Sci; 2004 Jun; 327(6):319-23. PubMed ID: 15201644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.
    Yki-Järvinen H; Ryysy L; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Salo S; Seppälä P; Tulokas T; Viikari J; Taskinen MR
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4037-43. PubMed ID: 9398709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the use of monocomponent pork insulin].
    Kang YH; Chi ZS; Qiu WS
    Zhonghua Nei Ke Za Zhi; 1988 May; 27(5):295-9, 327. PubMed ID: 3058421
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients.
    Waldhäusl WK; Bratusch-Marrain P; Kruse V; Jensen I; Nowotny P; Vierhapper H
    Diabetes; 1985 Feb; 34(2):166-73. PubMed ID: 3881304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the insulin antibody titre in severe form of diabetes mellitus].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies.
    Ishizuka T; Ogawa S; Mori T; Nako K; Nakamichi T; Oka Y; Ito S
    Diabetes Res Clin Pract; 2009 May; 84(2):e21-3. PubMed ID: 19328577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of insulin antibodies.
    Kansal PC; Bandisode MS; Boshell BR
    Horm Metab Res; 1979 Mar; 11(3):187-9. PubMed ID: 447197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma free insulin concentrations: keystone to effective management of diabetes mellitus in children.
    Malone JI; Root AW
    J Pediatr; 1981 Dec; 99(6):862-7. PubMed ID: 7031209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.